CONTENTS:
- Down the local: A qualitative case study of daytime drinking spaces in the London Borough of Islington. Thompson C., Milton S., Egan M., Lock K., p. 1-8.
- Chemsex, risk behaviours and sexually transmitted infections among men who have sex with men in Dublin, Ireland. Glynn R.W., Byrne N., O'Dea S., Shanley A., Codd M., Keenan E., et al., p. 9-15.
- Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia. Kikvidze T., Luhmann N., Avril E., Butsashvili M., Labartkava K., Etienne A., et al., p. 16-19.
- Re-thinking pre-drinking: Implications from a sample of teenagers who drink in private settings. Wilson J., Ogeil R.P., Lam T., Lenton S., Lloyd B., Burns L., et al., p. 20-24.
- The relationship between Australian harm minimisation alcohol education and student uptake, consumption and harm. Midford R., Lester L., Williams T., White V., p. 25-31.
- Experiences with compulsory drug detention among people who inject drugs in Bangkok, Thailand: A qualitative study. Kerr T., Small W., Ayutthaya P.P.N., Hayashi K., p. 32-38.
- Kalaban: Young drug users' engagements with law enforcement in the Philippines. Lasco G., p. 39-44.
- Associations between medical cannabis and other drug use among unstably housed women. Meacham M.C., Ramo D.E., Kral A.H., Riley E.D., p. 45-51.
- Identifying gaps in the implementation of naloxone programs for laypersons in the United States. Lambdin B.H., Zibbell J., Wheeler E., Kral A.H., p. 52-55.
- Perceptions about supervised injection facilities among people who inject drugs in Philadelphia. Harris R.E., Richardson J., Frasso R., Anderson E.D., p. 56-61.
- Becoming a medical marijuana user. Lankenau S.E., Kioumarsi A., Reed M., McNeeley M., Iverson E., Wong C.F., p. 62-70.
- The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives. Soussan C., Andersson M., Kjellgren A., p. 71-78.
- Ordering clinical realities: Controversy and multiplicity in alcohol and other drug treatment for young adults. Hart A., p. 79-86.
- Routes of administration for cannabis use - basic prevalence and related health outcomes: A scoping review and synthesis. Russell C., Rueda S., Room R., Tyndall M., Fischer B., p. 87-96.
- Multiple injections per injection episode: High-risk injection practice among people who injected pills during the 2015 HIV outbreak in Indiana. Broz D., Zibbell J., Foote C., Roseberry J.C., Patel M.R., Conrad C., et al., p. 97-101.
- Interpreting the Czech drug decriminalization: The glass is half full - Response to Cerveny, J., Chomynova, P., Mravcik, V., & van Ours, J.C. (2017). Cannabis decriminalization and the age of onset of cannabis use. Belackova V., Stefunkova M., p. 102-105.
- Being in control? A thematic content analysis of 14 in-depth interviews with 2,4-dinitrophenol users. Ainsworth N.P., Vargo E.J., Petroczi A., p. 106-114.
- Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era. Valerio H., McAuley A., Innes H., Palmateer N., Goldberg D.J., Munro A., et al., p. 115-122.